Literature DB >> 19098864

A report on the International Transglutaminase Autoantibody Workshop for Celiac Disease.

Marcella Li1, Liping Yu, Claudio Tiberti, Margherita Bonamico, Iman Taki, Dongmei Miao, Joseph A Murray, Marian J Rewers, Edward J Hoffenberg, Daniel Agardh, Patricia Mueller, Martin Stern, Ezio Bonifacio, Edwin Liu.   

Abstract

OBJECTIVES: Measurement of transglutaminase autoantibodies (TGAA) is considered to be the most efficient single serologic test for celiac disease (CD) by the American Gastroenterological Association Institute. We hypothesized that a large international collaborative effort toward improving and standardizing TGAA measurement is both feasible and necessary. The primary aim of this workshop is to compare TGAA assays among various research and clinical laboratories to examine assay concordance and improve (and eventually standardize) the TGAA assay.
METHODS: A total of 20 laboratories (5 commercial laboratories, 15 research and clinical laboratories) participated that included enzyme-linked immunosorbent assay (ELISA) and radiobinding assays. A total of 150 serum samples were distributed to each laboratory, with each laboratory receiving an equal aliquot that was coded and blinded, composed of 100 healthy control sera and 50 CD sera.
RESULTS: Laboratory sensitivity ranged from 69% to 93% and specificity ranged from 96% to 100%. By receiver operator characteristic analysis, the area under the curve (C index) ranged from 0.9488 to 0.9904. When analyzing for linear correlation, r-squared was as high as 0.8882 but as low as 0.4244 for the celiac samples between different laboratories performing ELISA.
CONCLUSIONS: This transglutaminase autoantibody workshop allows for larger-scale international participation for the purposes of improving and eventually standardizing the TGAA assay with subsequent workshops.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19098864      PMCID: PMC2904747          DOI: 10.1038/ajg.2008.8

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  13 in total

1.  Need for quantitative assessment of transglutaminase autoantibodies for celiac disease in screening-identified children.

Authors:  Edwin Liu; Marcella Li; Fei Bao; Dongmei Miao; Marian J Rewers; George S Eisenbarth; Edward J Hoffenberg
Journal:  J Pediatr       Date:  2005-04       Impact factor: 4.406

2.  Identification of tissue transglutaminase as the autoantigen of celiac disease.

Authors:  W Dieterich; T Ehnis; M Bauer; P Donner; U Volta; E O Riecken; D Schuppan
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

3.  A new approach to cytochrome CYP2D6 antibody detection in autoimmune hepatitis type-2 (AIH-2) and chronic hepatitis C virus (HCV) infection: a sensitive and quantitative radioligand assay.

Authors:  A M Yamamoto; C Johanet; J C Duclos-Vallee; F A Bustarret; F Alvarez; J C Homberg; J F Bach
Journal:  Clin Exp Immunol       Date:  1997-06       Impact factor: 4.330

4.  Radioimmunoassay to detect antitransglutaminase autoantibodies is the most sensitive and specific screening method for celiac disease.

Authors:  M Bonamico; C Tiberti; A Picarelli; P Mariani; D Rossi; E Cipolletta; M Greco; M D Tola; L Sabbatella; B Carabba; F M Magliocca; P Strisciuglio; U Di Mario
Journal:  Am J Gastroenterol       Date:  2001-05       Impact factor: 10.864

5.  Comparative evaluation of serologic tests for celiac disease: a European initiative toward standardization.

Authors:  M Stern
Journal:  J Pediatr Gastroenterol Nutr       Date:  2000-11       Impact factor: 2.839

6.  Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.

Authors:  A M Yamamoto; Z Amoura; C Johannet; A L Jeronimo; H Campos; S Koutouzov; J C Piette; J F Bach
Journal:  Arthritis Rheum       Date:  2000-03

Review 7.  International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.

Authors:  E Bonifacio; M Atkinson; G Eisenbarth; D Serreze; T W Kay; E Lee-Chan; B Singh
Journal:  Diabetes       Date:  2001-11       Impact factor: 9.461

8.  Diabetes Antibody Standardization Program: first assay proficiency evaluation.

Authors:  Polly J Bingley; Ezio Bonifacio; Patricia W Mueller
Journal:  Diabetes       Date:  2003-05       Impact factor: 9.461

9.  Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.

Authors:  Ivor D Hill; Martha H Dirks; Gregory S Liptak; Richard B Colletti; Alessio Fasano; Stefano Guandalini; Edward J Hoffenberg; Karoly Horvath; Joseph A Murray; Mitchell Pivor; Ernest G Seidman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-01       Impact factor: 2.839

10.  Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac disease.

Authors:  Britta Van Meensel; Martin Hiele; Ilse Hoffman; Severine Vermeire; Paul Rutgeerts; Karel Geboes; Xavier Bossuyt
Journal:  Clin Chem       Date:  2004-09-23       Impact factor: 8.327

View more
  37 in total

1.  Autoimmunity: Celiac disease in T1DM-the need to look long term.

Authors:  Marian Rewers; George S Eisenbarth
Journal:  Nat Rev Endocrinol       Date:  2011-11-08       Impact factor: 43.330

Review 2.  Advances in diagnosis and management of celiac disease.

Authors:  Ciarán P Kelly; Julio C Bai; Edwin Liu; Daniel A Leffler
Journal:  Gastroenterology       Date:  2015-02-03       Impact factor: 22.682

3.  The next big idea.

Authors:  Marian Rewers
Journal:  Diabetes Technol Ther       Date:  2013-06       Impact factor: 6.118

Review 4.  Testing for gluten-related disorders in clinical practice: the role of serology in managing the spectrum of gluten sensitivity.

Authors:  David Armstrong; Andrew C Don-Wauchope; Elena F Verdu
Journal:  Can J Gastroenterol       Date:  2011-04       Impact factor: 3.522

5.  High Incidence of Celiac Disease in a Long-term Study of Adolescents With Susceptibility Genotypes.

Authors:  Edwin Liu; Fran Dong; Anna E Barón; Iman Taki; Jill M Norris; Brigitte I Frohnert; Edward J Hoffenberg; Marian Rewers
Journal:  Gastroenterology       Date:  2017-02-07       Impact factor: 22.682

6.  Quality not quantity for transglutaminase antibody 2: the performance of an endomysial and tissue transglutaminase test in screening coeliac disease remains stable over time.

Authors:  K Swallow; G Wild; R Sargur; D S Sanders; I Aziz; A D Hopper; W Egner
Journal:  Clin Exp Immunol       Date:  2013-01       Impact factor: 4.330

7.  Inter- and Intra-assay Variation in the Diagnostic Performance of Assays for Anti-tissue Transglutaminase in 2 Populations.

Authors:  Prashant Singh; Alka Singh; Jocelyn A Silvester; Vikas Sachdeva; Xinhua Chen; Hua Xu; Daniel A Leffler; Vineet Ahuja; Donald R Duerksen; Ciaran P Kelly; Govind K Makharia
Journal:  Clin Gastroenterol Hepatol       Date:  2019-09-20       Impact factor: 11.382

8.  Feasibility of screening for T1D and celiac disease in a pediatric clinic setting.

Authors:  Patricia D Gesualdo; Kimberly A Bautista; Kathleen C Waugh; Liping Yu; Jill M Norris; Marian J Rewers; Judith Baxter
Journal:  Pediatr Diabetes       Date:  2015-08-06       Impact factor: 4.866

9.  Comparison of radioimmunoprecipitation with luciferase immunoprecipitation for autoantibodies to GAD65 and IA-2beta.

Authors:  Peter D Burbelo; Hiroki Hirai; Alexandra T Issa; Albert Kingman; Ake Lernmark; Sten-A Ivarsson; Abner L Notkins; Michael J Iadarola
Journal:  Diabetes Care       Date:  2010-01-19       Impact factor: 17.152

10.  Rapid serological detection of autoantibodies associated with Sjögren's syndrome.

Authors:  Peter D Burbelo; Kathryn H Ching; Alexandra T Issa; Caroline M Loftus; Yi Li; Minoru Satoh; Westley H Reeves; Michael J Iadarola
Journal:  J Transl Med       Date:  2009-09-24       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.